Technical Analysis for MVP - Medical Developments International Ltd  

Grade Last Price % Change Price Change
F 0.540 -3.57% -0.020
MVP closed down 3.57 percent on Friday, April 26, 2024, on 38 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Outside Day Range Expansion -3.57%
Oversold Stochastic Weakness -3.57%
Boomer Sell Setup Bearish Swing Setup -0.92%
Narrow Range Bar Range Contraction -0.92%

   Recent Intraday Alerts

Alert Time
Gap Down Closed about 20 hours ago
Rose Above Previous Day's High about 20 hours ago
Reversed from Down about 20 hours ago
Rose Above 10 DMA about 20 hours ago
Gap Down Partially Closed about 24 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medical Developments International Ltd   Description

Medical Developments International Limited is an Australia-based healthcare company. The Company is engaged in the manufacture and distribution of a pharmaceutical drug, and medical and veterinary equipment. The Company operates through three segments: Pharmaceuticals, Medical Devices and Veterinary products. The Pharmaceuticals segment is engaged in the sale of Penthrox primarily within Australia and the United Kingdom, and some sales in New Zealand, Eastern Europe, the Middle East and South America. The Medical Devices segment is engaged in the sale of medical devices, particularly the Space Chamber and Breath-Alert PeakFlow meters, primarily within Australia and New Zealand, and some sales in Asia, Europe, the Middle East and North America. The Veterinary Products segment is engaged in the sale of veterinary products within Australia, Europe and the United States. The Company offers a range of products in the areas of pain management, and asthma and resuscitation.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Healthcare Pharmaceutical Medical Device Pharmaceuticals Medical Devices Pharmaceutical Industry In China Asthma Veterinary Medicine Veterinary Physician Veterinary Products

Is MVP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.8
52 Week Low 0.54
Average Volume 194,315
200-Day Moving Average 0.864
50-Day Moving Average 0.695
20-Day Moving Average 0.581
10-Day Moving Average 0.557
Average True Range 0.025
RSI (14) 31.97
ADX 47.43
+DI 14.217
-DI 25.043
Chandelier Exit (Long, 3 ATRs) 0.560
Chandelier Exit (Short, 3 ATRs) 0.615
Upper Bollinger Bands 0.634
Lower Bollinger Band 0.527
Percent B (%b) 0.12
BandWidth 18.501
MACD Line -0.037
MACD Signal Line -0.041
MACD Histogram 0.004
Fundamentals Value
Market Cap 35.44 Million
Num Shares 65.6 Million
EPS 0.01
Price-to-Earnings (P/E) Ratio 90.00
Price-to-Sales 19.24
Price-to-Book 10.01
PEG Ratio 0.00
Dividend 0.04
Dividend Yield 7.41%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.578
Resistance 3 (R3) 0.582 0.573 0.571
Resistance 2 (R2) 0.573 0.564 0.571 0.569
Resistance 1 (R1) 0.557 0.558 0.553 0.553 0.567
Pivot Point 0.548 0.548 0.546 0.546 0.548
Support 1 (S1) 0.532 0.539 0.528 0.528 0.513
Support 2 (S2) 0.523 0.533 0.521 0.511
Support 3 (S3) 0.507 0.523 0.509
Support 4 (S4) 0.503